Choice Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 2.32 M
as on 20-12-2024
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.40 M
as on 20-12-2024
- Satisfied Charges ₹ 5.20 M
as on 20-12-2024
- Revenue 40.28%
(FY 2022)
- Profit 9894.71%
(FY 2022)
- Ebitda 5987.71%
(FY 2022)
- Net Worth 56.82%
(FY 2022)
- Total Assets 62.98%
(FY 2022)
About Choice Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.32 M.
The company currently has active open charges totaling ₹1.40 M. The company has closed loans amounting to ₹5.20 M, as per Ministry of Corporate Affairs (MCA) records.
Chitra Gopinathan and Gopinathan Karunakaran serve as directors at the Company.
- CIN/LLPIN
U85195KL2002PTC015595
- Company No.
015595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Malappuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Choice Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopinathan Karunakaran  | Managing Director | 02-Aug-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chitra Gopinathan | Director | 02-Aug-2012 | Current |
Financial Performance of Choice Diagnostics.
Choice Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.28% increase. The company also saw a substantial improvement in profitability, with a 9894.71% increase in profit. The company's net worth Soared by an impressive increase of 56.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Choice Diagnostics?
In 2018, Choice Diagnostics had a promoter holding of 46.65% and a public holding of 53.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Edappal Hospitals P LtdActive 39 years 1 monthChitra Gopinathan and Gopinathan Karunakaran are mutual person
Kannoly Medicorp Private LimitedActive 5 years 1 monthChitra Gopinathan and Gopinathan Karunakaran are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Federal Bank Limited Creation Date: 16 Oct 2007 | ₹1.40 M | Open |
Ge Capital Services India Ldtd Creation Date: 09 Jun 2003 | ₹5.20 M | Satisfied |
How Many Employees Work at Choice Diagnostics?
Unlock and access historical data on people associated with Choice Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Choice Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Choice Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
